scholarly journals Dipeptidyl Peptidase-4 Inhibitor Use Is Not Associated With Acute Pancreatitis in High-Risk Type 2 Diabetic Patients

Medicine ◽  
2016 ◽  
Vol 95 (7) ◽  
pp. e2603 ◽  
Author(s):  
Chia-Hsuin Chang ◽  
Jou-Wei Lin ◽  
Shu-Ting Chen ◽  
Mei-Shu Lai ◽  
Lee-Ming Chuang ◽  
...  
Keyword(s):  
Acute Pancreatitis ◽  
High Risk ◽  
Dipeptidyl Peptidase ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Dipeptidyl Peptidase 4 ◽  
Dipeptidyl Peptidase 4 Inhibitor ◽  
High Risk Type ◽  
Type 2 Diabetic

A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients

Metabolism ◽  
2013 ◽  
Vol 62 (3) ◽  
pp. 347-351 ◽  
Author(s):  
Noriko Satoh-Asahara ◽  
Yousuke Sasaki ◽  
Hiromichi Wada ◽  
Mayu Tochiya ◽  
Azusa Iguchi ◽  
...  
Keyword(s):  
Dipeptidyl Peptidase ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Dipeptidyl Peptidase 4 ◽  
Dipeptidyl Peptidase 4 Inhibitor ◽  
Anti Inflammatory ◽  
Type 2 Diabetic

Prognostic impact of clinic and ambulatory blood pressure components in high-risk type 2 diabetic patients

2013 ◽  
Vol 31 (11) ◽  
pp. 2176-2186 ◽  
Author(s):  
Gil F. Salles ◽  
Nathalie C. Leite ◽  
Basílio B. Pereira ◽  
Emilia M. Nascimento ◽  
Claudia R.L. Cardoso
Keyword(s):  
Blood Pressure ◽  
High Risk ◽  
Ambulatory Blood Pressure ◽  
Diabetic Patients ◽  
Prognostic Impact ◽  
Type 2 Diabetic Patients ◽  
High Risk Type ◽  
Type 2 Diabetic
Sign in / Sign up

Export Citation Format

Share Document